Expression of zinc-finger transcription factor Snail 1 in the kidney of diabetic rats

AIM: To explore the expression of Snail 1 in renal tissues of diabetic rats, and to investigate its contribution to the progression of diabetic nephropathy. METHODS: Streptozotocin-induced diabetic rats were randomly divided into 2, 4, 8, 12, 16, 20, 24 weeks groups and 16 week A, 20 week A and 24 week A groups. A groups were treated with insulin to control blood glucose to normal level from the 13th week. Control groups were set up in age-matched time points. Blood glucose, 24 h urine protein, serum creatinine (Scr) and kidney index of rats were measured. Periodic acid-silver (PAS) staining was used to observe the renal pathological changes. The mRNA and protein expressions of Snail 1 and FN in renal cortex were detected by RT-PCR and immunohistochemical staining, respectively. Western blotting was employed to detect the expression of Snail 1 protein in the renal cortex. RESULTS: The levels of blood glucose, Scr, kidney weight index were increased remarkably in diabetic rats as compared with those in control groups (P<0.05, P<0.01), and decreased remarkably in the insulin-treated rats as compared with those in the diabetic rats (P<0.05, P<0.01). The Snail 1 protein was not detected by immunohistochemical staining in normal renal tissues. However, strongly positive staining was observed in renal tubules of diabetic rats. A time-dependent loss of Snail 1 expression was detected in the kidney in insulin-treated rats. The Snail 1 protein and mRNA of Snail 1 and FN were significantly up-regulated in the diabetic rats as compared with those in controls (P<0.01), while down-regulated in the insulin-treated diabetic rats (P<0.01). A close positive relationship existed between the mRNA expression of Snail 1 and FN (r=0.800, P<0.01). The level of Snail 1 protein expression was positively correlated with blood glucose, urine protein, Scr, kidney index (r=0.877, 0.694, 0.522, 0.875, P<0.01).CONCLUSION: These findings suggest that Snail 1 gene and protein expression are up-regulated in the kidney of rats with diabetes and may be involved in the pathogenesis of diabetic nephropathy.     

GLP-1 down-regulates mRNA expression of SOCS-3 and SREBP-1c in rats with nonalcoholic fatty liver disease

AIM: To investigate the effects of glucagon-like peptide-1(GLP-1) on mRNA expression of SOCS-3 and SREBP-1c in the rats with nonalcoholic fatty liver disease. METHODS: Male SD rats were randomly divided into normal control(NC) group, high fat(HF) group and HF+liraglutide(Lira) group. The rats in HF group and HF+Lira group were given high-fat diet for 16 weeks. After 12 weeks of high-fat diet feeding in HF+Lira group, Lira(600 μg·kg^-1·d^-1) was intraperitoneally injected for 4 weeks. At the end of the 16th week, the rats were killed. The pathological changes of the liver were observed under optical microscope. The serum levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST), triglyceride(TG) and total cholesterol(TC) were detected by automatic biochemical analyzer. TG contents of liver were measured by GPO-PAP method. The fasting insulin(FINS) was determined by ELISA, and insulin resistance index was assessed by homeostasis mode assessment(HOMA-IR). The mRNA expression of SOCS-3 and SREBP-1c in the liver tissues was detected by RT-qPCR. RESULTS: Compared with NC group, HOMA-IR, TG of liver, and the serum levels of ALT, AST, TG, TC and FINS in HF group were obviously increased(P<0.01). Compared with HF group, HOMA-IR, TG of liver, and the serum levels of ALT, AST, TG, TC and FINS in HF+Lira group were all obviously decreased(P<0.05 or P<0.01). The mRNA expression of SOCS-3 and SREBP-1c in HF group was significantly higher than that in NC group(P<0.01). The mRNA expression of SOCSV3 and SREBP-1c in HF+Lira group was significantly decreased as compared with HF group(P<0.05). CONCLUSION: Liraglutide may improve the IR and reduce TG of liver through decreasing the mRNA expression of SOCS-3 and SREBP-1c, so as to play a therapeutic role in nonalcoholic fatty liver disease.     

Expression of LOX-1 in type 2 diabetic rat tubular interstitial tissues

AIM： To explore the effect of lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) on type 2 diabetic nephropathy in rats. METHODS：The Sprague-Dawley (SD) rats were randomly divided into control group and model group. The animal model was established by intraperitoneal injection of low-dose streptozotocin (STZ, 30 mg/kg) plus feeding with high-fat/high-glucose diets for one month. Biochemical parameters and 24 h urine album excretion rate (UAER) were monitored. The morphological changes of the renal tissue were examined under microscope with hematoxylin-eosin (HE) and periodic acid-Schiff reaction (PAS) staining. The protein levels of LOX-1 and transforming growth factor β1 (TGF-β1) in the renal tissues were determined by the method of immunohistochemistry. The mRNA expression of LOX-1 and TGF-β1 was detected by real-time polymerase chain reaction. The serum levels of monocyte chemotactic protein-1 (MCP-1), intercellular adhesion molecule (ICAM) and tumor necrosis factor α(TNF-α) were measured by enzyme-linked immunosorbent assay (ELISA). The correlation between LOX-1 and UAER, inflammatory factors and TGF-β1 was analyzed. RESULTS：Compared with normal group, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and UAER in model groups markedly increased, high-density lipoprotein (HDL) only increased at 0 week, then decreased at 4 and 8 weeks. The expression of LOX-1 and TGF-β1 at mRNA and protein levels was increased, as well as the concentration of serum inflammatory factors such as MCP-1, ICAM and TNF-α. The obvious relations between LOX-l mRNA with UAER, TNF-α and TGF-β1 were observed (r=0.509, 0.649 and 0.800, respectively, P<0.05). CONCLUSION：LOX-1 is significantly increased in type 2 diabetic rat tubular interstitial tissues and aggravates the dysfunction of renal tubules by releasing inflammatory factors and promoting inflammatory cell infiltration.     

Expression and significance of thrombospondin-1 in myocardium of type 2 diabetic cardiomyopathy rats

AIM: To investigate the expression and significance of thrombospondin-1 (TSP-1) in left ventricular myocardium of type 2 diabetic cardiomyopathy (DCM).METHODS: The rat model of DCM was established by eating a high-fat diet together with injection of low dose streptozocin (30 mg/kg) intrapertoneally.After 12 weeks,the content of collagen was quantified by Masson staining.The mRNA level of TSP-1 was determined by quantification real-time RT-PCR,while the protein level of TSP-1 was analyzed by Western blotting and immunohistochemistry.RESULTS: Compared with the control group,the content of collagen in the DCM group was increased greatly (11.01±3.05 vs 16.92±3.18,P<0.01).The mRNA and protein expressions of TSP-1 were significantly higher than those in control group (0.0089±0.0034 vs 0.0141±0.0037,P<0.05；96.38±16.80 vs 129.98±16.96,P<0.05).In DCM group,the mRNA and protein expressions of TSP-1 showed significantly positive correlations with the levels of fasting blood glucose and collagen (r=0.762,P<0.01; r=0.717,P<0.05; r=0.735,P<0.01; r=0.750,P<0.01).There was a significantly positive correlation of TSP-1 mRNA level with LVEDP (r=0.658,P<0.05).In contrast,there was a significantly negative correlation of TSP-1 protein with LVSP and -dp/dtmax (r=-0.605,P<0.05; r=-0.694,P<0.05).There was a significantly positive correlation of TSP-1 protein with LVEDP (r=0.716,P<0.05).There was a significantly negative correlation of TSP-1 protein with LVSP and -dp/dtmax (r=-0.633,P<0.05; r=-0.669,P<0.05).CONCLUSION: The increased expression of TSP-1 may play an important role in the development of myocardial interstitial fibrosis in DCM.     

Protective effect of pyrrolidine dithiocarbamate on kidneys in type 2 diabetic rats

AIM: To investigate the protective effect of pyrrolidine dithiocarbamate (PDTC) on the kidneys in type 2 diabetic rats. METHODS: High-fat diet and a small dose (27 mg/kg) of streptozotocin-induced diabetic rats were treated with or without PDTC (50 mg穔g^-1穌^-1, ip) for 1 week, and age-matched nondiabetic animals were also used for comparison. The concentration of malondialdehyde (MDA)and the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were determined by commercial kit. The ratio of urine microalbumin/creatinine was measured by an automatic biochemical analyzer. The morphological changes of renal glomerulus were observed by HE/Masson staining and transmission electron microscopy. The expression of inducible nitric oxide synthase (iNOS) and nitrotyrosine (NT) in the renal tissues was examined by the method of immunohistochemistry. RESULTS: PDTC-treated rats had lower blood glucose level and urine microalbumin/creatinine ratio than those in untreated diabetic rats. The levels of tissue MDA in diabetic rats were significantly higher, and the activity of SOD and GSH-Px was lower than those in normal control rats (P<0.05). The renal damage in diabetic rats was significantly improved after PDTC treatment. PDTC administration markedly attenuated the expression of iNOS and the production of NT in renal glomerulus and tubule in diabetic rats. CONCLUSION: PDTC not only reduces blood glucose level, but also protects the diabetic rats from diabetic nephropathy by diminishing the expression of iNOS and the production of NT.     

Changes in serum TGF β1 in type 2 diabetic patients

AIM: To explore the changes in serum TGF β₁ in type 2 diabetes mellitus. METHODS: Forty-five cases type 2 diabetes mellitus patients were divided into three groups according to urine albumim excretion rate(UAER): normoalbuminuria(NA)group and microalbuminuria(MA) group and macroalbuminuria group (Overt DN). Serum TGF β₁, fasting blood glucose(FBG), HbA_1c,BUN,Cr,Ccr,lipidemia were detected in all cases. RESULTS: Serum TGF β₁ in NA, MA and ODN groups was higher than that in control. Serum TGF β₁ was positive correlation with Cr(r=0.390,P＜0.05), LDL(r=0.503,P＜0.01), HbA_1c (r=0.676,P＜0.01), and UARE(r=0.777,P＜0.01). CONCLUSION: Type 2 diabetes mellitus have a higher serum TGF β₁ than controls, serum TGF β₁ was positive correlation with HbA_1c and injury of renal function.     

Role of focal adhesion kinase expression in renal tissues of type 2 diabetic rats

AIM：To explore the dynamic change of focal adhesion kinase (FAK) in renal tissues of rats with type 2 diabetes mellitus (T2DM), and to investigate its role in the pathogenesis of diabetic nephropathy (DN). METHODS：The rat model of T2DM was established and the diabetic rats were randomly divided into 8-week DM (DM8), 12-week DM (DM12) and 16-week DM (DM16) groups. Meanwhile, normal control (NC) and high-fat high-sucrose control (HC) groups were also established. The protein expression of FAK, transforming growth factor β1 (TGF-β1), extracellular signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2 and fibronectin (FN) was detected by immunohistochemical staining. The protein levels of FAK and p-FAK (Tyr397) were detected by Western blotting. The mRNA level of FAK in the renal cortex was examined by RT-PCR. RESULTS：The expression of FAK protein in renal tubular epithelial cells in DM12 and DM16 groups was significantly higher than that in NC, HC and DM8 groups (P<0.05). Moreover, TGF-β1, p-ERK1/2 and FN protein expression in DM groups was significantly increased compared with NC and HC groups (P<0.05). The levels of FAK and p-FAK (Tyr397) in the renal cortex in DM12 and DM16 groups were significantly up-regulated compared with NC, HC and DM8 groups (P<0.05), and the expression trend of p-FAK in different groups was in accordance with that of total FAK. The FAK protein expression was positively correlated with the expression of TGF-β1, p-ERK1/2 and FN proteins (P<0.01). Compared with NC, HC and DM8 groups, the expression of FAK mRNA increased remarkably in DM12 and DM16 groups (P<0.05). CONCLUSION: There is a possibility that FAK is activated as a downstream effector of TGF-β1 in T2DM, which enhances the expression of FN protein through activating ERK1/2, and therefore plays an important role in the pathogenesis of type 2 diabetic nephropathy.     

Expression of Raf kinase inhibitor protein and p-ERK in renal tissues of diabetic rats

AIM: To investigate the expression of Raf kinase inhibitor protein (RKIP) and phosphorylated extracellular signal-regulated kinase (p-ERK) in the renal tissues of diabetic rats. METHODS: Forty SD rats were randomly divided into normal control group and diabetic nephropathy group. The pathological changes of the renal tissues were observed under microscope with HE and periodic acid-Schiff (PAS) staining. The expression of RKIP and p-ERK1/2 was detected by the methods of immunohistochemistry and Western blotting. RESULTS: Following the extension of duration, the blood sugar of the rats in diabetic nephropathy group increased, with the appearance of proteinuria, increase in kidney weight, increase in renal p-ERK1/2 expression and decrease in RKIP expression as compared with control group. CONCLUSION: The development of diabetic nephropathy may be accelerated by the decrease in RKIP and the increase in p-ERK.     

Protective effects of Zhenwu decoction on kidney injury of diabetic rats induced by streptozotocin

AIM：To investigate the effects of Zhenwu decoction (ZWD) on the expression of α-smooth muscle actin (α-SMA) and NF-κB in diabetic nephropathy (DN) rats. METHODS：Diabetic rat model was induced by intrape-ritoneal injection of streptozotocin (STZ), and the animals were randomly divided into STZ group (n=22) and STZ+ZWD group (n=23). The normal rats served as control (n=16). All rats were sacrificed on 8 weeks after modeling. Biochemical assay and pathological observation (HE staining and transmission electron microscopy) were used to evaluate the effects of Zhenwu decoction on the renal function and pathological morphology. The body weight, renal index, blood glucose, total urinary protein in 24 h, and superoxide dismutase (SOD), malondialdehyde (MDA),inducible nitric oxide synthase (iNOS) were determined as well. Western blotting was used to observe the effects of Zhenwu decoction on the expression of α-SMA and NF-κB in diabetic nephropathy (DN) rats. RESULTS：Compared with normal group, the renal index, blood glucose concentration, total urinary protein in 24 h, blood urea nitrogen (BUN), serum creatinine (SCr) and MDA were significantly higher and body weight was lower in DN rats (P<0. 05). Pathological examination of the kidneys in DN group showed glomerular hypertrophy, glomerular basement membrane thickening, tubular epithelial cell degeneration, mesangial matrix proliferation, protein cast formation in some renal tubules. The protein expression levels of α-SMA and NF-κB were markedly increased (P<0.05). After ZWD treatment, the level of renal index, total urinary protein in 24 h, BUN, SCr and the expression of α-SMA and NF-κB at the protein level were significantly decreased (P<0.05). The renal histological injury in ZWD group was significantly ameliorated. CONCLUSION：Zhenwu decoction might protect kidney against STZ-induced injury via decreasing the expression of α-SMA and NF-κB.     

Renal protective effect of spirinolactone and cilazapril on diabetic rats

AIM: To assess the renal protective effect of the combination use of spirinolactone and cilazapril on streptozotocin(STZ)-induced diabetic rats with single nephrectomy. METHODS: Diabetic nephropathies were induced by intraperitoneal injection of STZ in the rats with single nephrectomy. The rats were randomly divided into 5 groups: normal control; diabetes; diabetes treated with spirinolactone; diabetes treated with cilazapril; diabetic rats treated with spirinolactone and cilazapril. The expression of NF-κB and PAI-1 in the glomeruli was detected by immunohistochemical staining. RT-PCR was performed to evaluate the mRNA expression of AT-1R. RESULTS: Increased 24 h urinary protein, decreased Ccr and the pathological injury of the renal tissues were improved by the treatment with either spirinolactone or cilazapril alone and further ameliorated by using the combination of the two drugs. The activity of NF-κB and PAI-1 was higher in the renal tissues of diabetic rats than that in control group, and further attenuated by the combination therapy in both cases (P<0.05). The over-expression of AT-1R mRNA observed in the diabetic rats was attenuated by treating with spirinolactone or cilazapril and further reduced by the combination use of the two drugs (P<0.05).CONCLUSION: The combination use of spirinolactone and cilazapril confers superiority over monotherapy on the effect of renal protection. The mechanism may be partly correlated with synergistic suppression of the increasing activity of NF-κB and PAI-1 as well as the over-expression of AT-1R mRNA in renal tissues.     

Effect of irbesartan on nephrin expression in the podocyte of early diabetic nephropathy rats

AIM: To investigate the expression of the nephrin in podocyte of the diabetic nephropathy(DN) rats and the mechanism of irbesartan-induced renal protection.METHODS: The DN model was established by a single injection of streptozotocin(STZ),and DN rats were randomly divided into 2 groups: model group and irbesartan treatment group.In addition,the normal rats served as a normal control group. All the rats were received daily gavage respectively for 8 weeks. The urinary protein quality in 24 hours,body weight(BW),kidney weight (KW),KW/BW,glucemia,urea nitrogen,creatinine,total cholesterol, triacylglycerol were detected with correlative methods and the pathological changes of kidney were also detected with optic microscope and transmission electron microscope.The expression of nephrin in podocyte were detected by immunohistochemistry. RESULTS: In DN rats, irbesartan reduced the urinary protein quality in 24 hours (P<0.01) and alleviated the damage of kidney. Meanwhile，the expression of nephrin was declined remarkably in podocytes in irbesartan treatment group compared with model group（P<0.05）.CONCLUSION: Irbesartan might protect kidney against STZ-induced injury via decreasing the expression of nephrin in podocytes.     

Influence of Xiaoke keli Ji on glycemia and serum lipoprotein levels in diabetic nephropathy rats

AIM:To observe the changes of glycemia and serum cholesterol and triglyceride in diabetic nephropathy rats and therapeutic effects of Xiaoke Keli Ji.METHODS:3/4 nephrectomy was adopted firstly, three weeks later streptozotocin(STZ) was administered intraperitoneally to establish diabetic nephropathy model in rats. Animals were divided into four groups:model group, Xiaoke Keli Ji treatment group, positive control group and sham group. Changes of serum sugar and serum creatinine, cholesterol and triglyceride were examined at 1, 2, 3, 4, 5 weeks after STZ injection. Renal tissue samples were adopted at 6th week and studied by light microscopy.RESULTS:Model group demonstrated different degree of glomerular sclerosis. Lesions in treatment group were alleviated. Serum creatinine, serum sugar and serum cholesterol were higher at 1, 2, 3, 4, 5 weeks after STZ injection in model group than that of the sham group (P＜0. 05), serum triglyceride was higher at 1, 2, 3, 5 weeks after STZ injection in model group than that of the sham group(P＜0. 05). Xiaoke Keli Ji reduced those changes. Serum sugar was in positive correlation with serum lipoprotein.CONCLUSION:Diabetic nephropathy model was duplicated successfully. High serum sugar may lead to high serum lipoprotein, Xiaoke Keli Ji may treat diabetic nephropathy by reducing serum sugar and serum cholesterol and triglyceride.     

Expression and probable role of extracellular signal-regulated protein kinases in renal fibrosis associated with diabetic in mice

AIM: To investigate the expression and probable role of extracellular signal-regulated protein kinase (ERK1/2) in renal fibrosis associated with diabetic in mice.METHODS: Male homozygous C57BL/6 mice were divided at random into control group (intraperitoneally injected with citrate buffer) and diabetes group (received 5 consecutive daily intraperitoneal injections of streptozotocin at dose of 50 mg·kg^-1·d^-1).All mice were followed up for 16 weeks.Diabetes was confirmed by serum glucose levels exceeding 16.7 mmol/L.Mice were killed at 0,4,8,12 and 16 weeks respectively after streptozotocin injection.The kidney tissues were obtained from diabetic and control mice.Serum glucose,kidney weight/body weight (KW/BW),24 h albumin excretion rate (UAE) and the serum creatinine (Scr) were measured.The kidney tissue was used for histological and morphometric studies of glomerular size,glomerular matrix expansion (PAS),and the expression of TGF-β₁,phosphorylated ERK1/2 and collagen Ⅲ by immunohistochemical staining.RESULTS: The serum level of glucose in streptozotocin -induced diabetic mice increased significantly.The kidney weight/body weight ratio,glomerular volume and glomerular matrix expansion in diabetic mice were obviously higher than those in control mice.Serum creatinine and 24 h albumin excretion rate in diabetic mice increased significantly compared with control mice.TGF-β₁,phosphorylated ERK1/2 and collagen Ⅲ levels were obviously increased in the kidney of diabetic mice compared with those in control mice (P<0.01).TGF-β₁ expression was positively related to the expression of phosphorylated ERK1/2.CONCLUSION: The overexpression of phosphorylated ERK1/2 in diabetic kidney may play an important role in the development of renal fibrosis associated with diabetic nephropathy in mice.     

Effect of Xuefuzhuyu decoction on cardiomyopathy in type 2 diabetic rats

AIM: To observe the pathologic changes of cardiomyopathy in type 2 diabetic rats and the therapeutic effect of Xuefuzhuyu decoction.METHODS: The diabetic model was established by feeding the animals with high-fat diet and injecting a middle dose of streptozotocin (50 mg/kg) intraperitoneally in 42 Wistar male rats. After 8 weeks, the damage of the heart in the model animals was detected by electrocardiogram and echocardiography, and the serum level of glucose, total cholesterol and triglyceride were determined by the methods of clinical chemistry. The content of collagen was quantified by Masson staining. The apoptosis of cardiomyocytes was measured by TUNEL apoptosis kit. The structures of myocardial damage were observed under light and electronic microscopes.RESULTS: (1) Compared with normal group at the same time points, the contents of serum glucose, triglyceride and cholesterol in model group increased (P<0.05). At the 11th and 14th weeks, the thickness of LVDS was significantly increased (P<0.01), the structure of myocardial tissues was severely damaged and collagen fiber content increased obviously (P<0.01). The cell apoptosis was also increased. (2) Compared with control group at the same time points, the contents of serum glucose, cholesterol and triglyceride in Xuefuzhuyu decoction group significantly decreased (P<0.05). The thickness of LVDS at the 11th and 14th weeks was decreased (P<0.05) and LVM at the 14th week became significantly thinner (P<0.01). The damage of the myocardium and subcellular structure was slighter and the content of collagen was lower than that in control group (P<0.05). The cell apoptosis was also attenuated.CONCLUSION: The levels of blood glucose, total cholesterol and triglyceride and the content of collagen fibers increase when diabetic cardiomyopathy develops, with more cell apoptosis and severe damage in the cardiac structure. Xuefuzhuyu decoction decreases the level of blood lipid in diabetic cardiomyopathy, alleviates the pathological changes of myocardial fibrosis and delays the progression of diabetic cardiomyopathy.     

Effect of astragalus polysaccharin on expression of nephrin and podocin in podocytes of early diabetic nephropathy rats

AIM: To observe the effects of astragalus polysaccharin (APS) on the expression of nephrin and podocin in podocytes of diabetic nephropathy (DN) rats.METHODS: The rat model of diabetes was induced by intraperitoneal injection of streptozotocin (STZ).The diabetic rats were randomly divided into 2 groups by the treatment without or with APS: STZ group (n=8) and STZ+APS group (n=8).In addition, 8 non-treated rats served as control.All the rats were treated with APS or normal saline orally by gavage for 8 weeks.The concentration of blood glucose was monitored on week 2, 5 and 8 after treatment.Eight weeks later, the body weight and renal index were measured.Total urine protein in 24 h, blood urea nitrogen (BUN) and serum creatinine (SCr) were detected by biochemical methods.The pathological changes of the kidneys were also observed under light microscope.The protein levels of nephrin and podocin in the kidney tissues were also determined by Western blotting.RESULTS: After APS intervention, the levels of renal index, blood glucose concentration, 24-hour total urine protein, BUN and SCr were significantly lower and body weight was higher than those in STZ group (P<0.05).The renal pathological status in APS group was significantly improved and the expression levels of nephrin and podocin also markedly increased (P<0.05).CONCLUSION: APS might protect kidney against STZ-induced injury via increasing the expression of nephrin and podocin in podocytes.